Masimo Corp(MASI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 123.41 | EPS (ttm) | 1.46 | Insider Own | 2.94% | Shs Outstand | 52.4M | Perf Week | - |
| Market Cap | 9.42B | Forward P/E | 26.9 | EPS next Y | 10.76% | Insider Trans | -1.2% | Shs Float | 50.8M | Perf Month | 0.64% |
| Enterprise Value | 9.79B | PEG | - | EPS next Q | - | Inst Own | 94.61% | Short Float | 6.89% | Perf Quarter | 2.2% |
| Income | 0.08B | P/S | 6.05 | EPS this Y | 57.7% | Inst Trans | - | Short Ratio | 3.08 | Perf Half Y | 30.97% |
| Sales | 1.56B | P/B | 11.95 | EPS next 5Y | - | ROA | 11.02% | Short Interest | 3.50M | Perf YTD | 38.36% |
| Book/sh | 15.06 | P/C | 75.63 | EPS past 3/5Y | - | ROE | 24.99% | 52W High | -0.02% ($179.99) | Perf Year | 4.7% |
| Cash/sh | 2.38 | P/FCF | 44.68 | Sales past 3/5Y | -9.14% 5.95% | ROIC | 5.99% | 52W Low | 42.89% ($125.94) | Perf 3Y | 15.1% |
| Dividend Est. | - | EV/EBITDA | 28.14 | EPS Y/Y TTM | 116.03% | Gross Margin | 61.73% | Volatility(W/M) | 0.09% 0.16% | Perf 5Y | -15.37% |
| Dividend TTM | - | EV/Sales | 6.28 | Sales Y/Y TTM | -21.03% | Oper. Margin | 19.86% | ATR (14) | 0.39 | Perf 10Y | 243.29% |
| Dividend Ex-Date | 2012/11/23 | Quick Ratio | 1.45 | EPS Q/Q | 133.86% | Profit Margin | 4.84% | RSI (14) | 74.83 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.68 | Sales Q/Q | 8.49% | SMA20 | 0.65% ($178.79) | Beta | 1.09 | Target Price | $180 |
| Payout | - | Debt/Eq | 0.62 | Earnings | 2026/05/12 | SMA50 | 0.78% ($178.56) | Rel Volume | 0 | Prev Close | $179.95 |
| Employees | 7500 | LT Debt/Eq | 0.6 | EPS/Sales Surpr. | -112.17% 1.1% | SMA200 | 15.43% ($155.9) | Avg Volume(3M) | 1.14M | Price | $179.95 |
| IPO | 2007/8/8 | Option/Short | Yes/No | Trades | 0 | Volume | - | Change | - |
Company
MASI is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A U.S. medical device company that supplies patient monitoring equipment and sensors to hospitals, including devices that measure blood oxygen saturation. Its strengths lie in its recurring revenue from disposable sensors used for each patient and its measurement technology.
Over the past 1 year, on the higher side
0% below its 1-year high.
MASI makes money exceptionally well
19.86% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +57.7% this year.
Tap to view numbers
But it is not cheap
Trading at 123.4 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by +15.1% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 94.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
RSBA 0.12%
HEAL 0.04%
NTRL 0.04%
MARB 0.04%
EVNT 0.03%It ranks #4 in the industry
Based on market cap of $9B.
MASI $9B PER 123.4
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
FAQ
What kind of company is MASI?
MASI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of MASI?
The market cap of MASI is approximately $9.4B, ranking 975 within its sector.
What is the P/E ratio of MASI?
MASI has a P/E ratio of approximately 123.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for MASI?
MASI has recorded a 52-week high of $179.99 and a low of $125.94.
